These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15804810)

  • 1. Investigation of anticancer activity of macrocyclic Schiff bases by means of 4D-QSAR based on simplex representation of molecular structure.
    Kuz'min VE; Artemenko AG; Lozytska RN; Fedtchouk AS; Lozitsky VP; Muratov EN; Mescheriakov AK
    SAR QSAR Environ Res; 2005 Jun; 16(3):219-30. PubMed ID: 15804810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of structure-anticancer and antiviral activity relationships for macrocyclic pyridinophanes and their analogues on the basis of 4D QSAR models (simplex representation of molecular structure).
    Kuz'min VE; Artemenko AG; Lozitsky VP; Muratov EN; Fedtchouk AS; Dyachenko NS; Nosach LN; Gridina TL; Shitikova LI; Mudrik LM; Mescheriakov AK; Chelombitko VA; Zheltvay AI; Vanden Eynde JJ
    Acta Biochim Pol; 2002; 49(1):157-68. PubMed ID: 12136936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
    Muratov EN; Artemenko AG; Varlamova EV; Polischuk PG; Lozitsky VP; Fedchuk AS; Lozitska RL; Gridina TL; Koroleva LS; Sil'nikov VN; Galabov AS; Makarov VA; Riabova OB; Wutzler P; Schmidtke M; Kuz'min VE
    Future Med Chem; 2010 Jul; 2(7):1205-26. PubMed ID: 21426164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the structure-anticancer activity relationship in a set of Schiff bases of macrocyclic 2,6-bis(2- and 4-formylaryloxymethyl)pyridines.
    Kuz'min VE; Lozitsky VP; Kamalov GL; Lozitskaya RN; Zheltvay AI; Fedtchouk AS; Kryzhanovsky DN
    Acta Biochim Pol; 2000; 47(3):867-75. PubMed ID: 11310986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity prediction of some nontested anticancer compounds using GA-based PLS regression models.
    Nandi S; Bagchi MC
    Chem Biol Drug Des; 2011 Oct; 78(4):587-95. PubMed ID: 21752199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR study of isatin analogues as in vitro anti-cancer agents.
    Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
    Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
    Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
    Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity.
    Liao SY; Qian L; Miao TF; Lu HL; Zheng KC
    Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: anticancer drug design by computed descriptors.
    Nandi S; Bagchi MC
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):937-48. PubMed ID: 19555178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TOPological Sub-structural Molecular Design (TOPS-MODE)-QSAR approach for modeling the antiproliferative activity against murine leukemia tumor cell line (L1210).
    Molina-Ruiz R; Saíz-Urra L; Rodríguez-Borges JE; Pérez-Castillo Y; González MP; García-Mera X; Cordeiro MN
    Bioorg Med Chem; 2009 Jan; 17(2):537-47. PubMed ID: 19114309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchic system of QSAR models (1D-4D) on the base of simplex representation of molecular structure.
    Kuz'min VE; Artemenko AG; Polischuk PG; Muratov EN; Hromov AI; Liahovskiy AV; Andronati SA; Makan SY
    J Mol Model; 2005 Nov; 11(6):457-67. PubMed ID: 16237516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
    Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
    Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.
    Ekins S; Bravi G; Binkley S; Gillespie JS; Ring BJ; Wikel JH; Wrighton SA
    Pharmacogenetics; 1999 Aug; 9(4):477-89. PubMed ID: 10780267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchical QSAR technology based on the Simplex representation of molecular structure.
    Kuz'min VE; Artemenko AG; Muratov EN
    J Comput Aided Mol Des; 2008; 22(6-7):403-21. PubMed ID: 18253701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
    Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
    Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents.
    Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H
    Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
    Nikolic K; Agababa D
    J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J; Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2170-9. PubMed ID: 14632469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.